| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080227099 Assay for identifying modulators of cholesterol efflux; treating cardiovascular disorders |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226756 Compositions comprising a c-glycoside compound |
| 09/18/2008 | US20080226753 Cry proteins; blending seed mixtures then planting; herbicide resistance |
| 09/18/2008 | US20080226739 Hierarchically self-assembling linear-dendritic hybrid polymers for delivery of biologically active agents |
| 09/18/2008 | US20080226737 Use of Calcitonin For the Treatment of Ra |
| 09/18/2008 | US20080226730 Particles for inhalation having rapid release properties |
| 09/18/2008 | US20080226724 Prevention of hydrogel viscosity loss |
| 09/18/2008 | US20080226723 Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same |
| 09/18/2008 | US20080226722 Gel Composition Comprising Charged Polymers |
| 09/18/2008 | US20080226720 Cultured cells having a wound healing phenotype, wherein the cells have higher levels of expression of expression of apolipoprotein D, matrix metalloprotease 2, and collagen 3a1 relative to the expression level of Ribosomal protein L32; chronic open lesions slow or resistant to healing; cell therapy |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/18/2008 | US20080226707 WNT compositions and methods of use thereof |
| 09/18/2008 | US20080226706 Use of Repeat Sequence Protein Polymers in Personal Care Compositions |
| 09/18/2008 | US20080226703 Human Growth Hormone Patch Formulations |
| 09/18/2008 | US20080226687 Drug delivery and method having coated microprojections incorporating vasoconstrictors |
| 09/18/2008 | US20080226681 Highly Active Glycoproteins-Process Conditions and an Efficient Method for their Production |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226668 Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes |
| 09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 09/18/2008 | US20080226665 EphA2 T-cell epitopes and uses therefor |
| 09/18/2008 | US20080226664 Colon cancer antigen panel |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226661 Using immunoaffinity recognition to identify phage clones expressing mycoplasma peptides; developing vaccines for prevention and treatment of contagious bovine pleuropneumonia |
| 09/18/2008 | US20080226657 Monomethylvaline compounds capable of conjugation to ligands |
| 09/18/2008 | US20080226655 Kallikrein-Inhibitor Therapies |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226651 Envelope protein specific immunoglobulin for use in treatment and prevention human immunodeficieny virus infection |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226645 Methods and compositions for assessment and treatment of asthma |
| 09/18/2008 | US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226639 Heparin Binding Peptide |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226633 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226631 Methods of modulating cytokine activity; related reagents |
| 09/18/2008 | US20080226628 CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof |
| 09/18/2008 | US20080226627 Using clostridium botulinum neurotoxin complex (Hn-33) protein as diagnostic tool in identifying modulators for treatment and prevention of clostridial poisoning; antitumor agents |
| 09/18/2008 | US20080226625 Stable non- aqueous single phase viscous vehicles and formulations utlizing such vehicles |
| 09/18/2008 | US20080226623 Stabilized protein crystals, formulations comprising them and methods of making them |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226617 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 09/18/2008 | US20080226616 Mixture comprising polyacrylic acid salts, acrylate/C10-30 alkyl acrylate crosspolymer and carrageenan for use as agent which reduces cellulite and skin irregularities |
| 09/18/2008 | US20080226615 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 09/18/2008 | US20080226610 Expression vector comprising nucleotide sequences coding syncytium-inducing polypeptide for use in targeting tumor cells for destruction; antitumor agents |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226599 Methods of treatment involving p21/CIP1 |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |
| 09/18/2008 | US20080226597 Viricidal protein for prevention and treatment of hepatitis infection |
| 09/18/2008 | US20080226596 Therapeutic compositions and methods useful in treating hepatitis |
| 09/18/2008 | US20080226595 Using placental stem cell inoculation comprising anti-inflammatory, inteferon and/or immunosuppressant supplements as therapeutic in treatment of cell proliferative and inflammatory disorders |
| 09/18/2008 | US20080226594 Culturing circular ssdna viruses for the production of vaccines |
| 09/18/2008 | US20080226593 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | US20080226592 Enzyme inhibitors; interferons; interleukins; cyclosporins |
| 09/18/2008 | US20080226591 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | US20080226590 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | US20080226589 Compositions and methods of use of phorbol esters |
| 09/18/2008 | US20080226588 Treating melanoma with bis(thiohydrazide amides) |
| 09/18/2008 | US20080226587 Methods and compositions for immunomodulation |
| 09/18/2008 | US20080226586 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 09/18/2008 | US20080226568 Mixture of oil miscible glycol and enzyme; fungicide, bactericide, microbiocides; efficiency; formaldehyde-free |
| 09/18/2008 | US20080226560 Supplying cargo compound into cancer cells; cargo compound may be nucleic acids, Dna, Rna |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | CA2718127A1 Gene expression in peripheral blood mononuclear cells from children with diabetes |
| 09/18/2008 | CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 09/18/2008 | CA2680899A1 Tighter-binding c-peptide inhibitors of hiv-1 entry |
| 09/18/2008 | CA2680824A1 Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| 09/18/2008 | CA2680818A1 Growth hormone secretion stimulator |
| 09/18/2008 | CA2680792A1 Treatment of autoimmune disorders |
| 09/18/2008 | CA2680759A1 Kunitz-type recombinant inhibitor |
| 09/18/2008 | CA2680704A1 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing |
| 09/18/2008 | CA2680556A1 Biomarkers of prostate cancer and uses thereof |
| 09/18/2008 | CA2680544A1 Skin-whitening agent |
| 09/18/2008 | CA2680236A1 Protective agents for transplanted organs |
| 09/18/2008 | CA2680122A1 Pharmaceutical composition |
| 09/18/2008 | CA2679497A1 Diagnostic and therapeutic aspects of sparc promoter hypermethylation in colon cancer |
| 09/18/2008 | CA2676083A1 Novel multimeric molecules, method for preparing same and use thereof in the preparation of drugs |
| 09/18/2008 | CA2666908A1 Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures |
| 09/17/2008 | EP1970386A2 Hybrid immunoglobulins |
| 09/17/2008 | EP1970383A1 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 09/17/2008 | EP1970382A1 Activated collagen scaffold materials and their special fused active restoration factors |
| 09/17/2008 | EP1970380A1 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof |
| 09/17/2008 | EP1970379A1 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus |
| 09/17/2008 | EP1970073A1 Enterococcus antigens and vaccines |
| 09/17/2008 | EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism |
| 09/17/2008 | EP1970071A1 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 09/17/2008 | EP1970070A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/17/2008 | EP1970058A1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 09/17/2008 | EP1969120A2 Skin care compositions and treatments |
| 09/17/2008 | EP1969007A2 Compositions and methods for producing a composition |
| 09/17/2008 | EP1969005A1 Apoptosis-inducing protein complexes and therapeutic use thereof |
| 09/17/2008 | EP1969004A2 Compositions comprising an acylated insulin and zinc and method of making the said compositions |
| 09/17/2008 | EP1969003A1 Novel neurotrophic factor protein and uses thereof |